GLPG1205   Click here for help

GtoPdb Ligand ID: 10171

Synonyms: compound 122 [WO2013092791A1] | GLPG-1205
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: GLPG1205 is an investigational, orally bioavailable GPR84 antagonist that was being developed by Galapagos. The chemical structure is claimed as compound 122 in patent WO2013092791A1, for the treatment of inflammatory disorders [1]. Galapagos cut GLPG1205 (for idiopathic pulmonary fibrosis, IPF) from their development pipeline in a cost-cutting exercise in the first half of 2021. Their chitinase inhibitor, GLPG4617 (structure undisclosed), will be taken forward into a phase 2 study for IPF.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 3
Topological polar surface area 62.58
Molecular weight 378.16
XLogP 4.67
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1nc(OCC2COCCO2)cc2n1CCc1c2ccc(c1)C#CC1CC1
Isomeric SMILES O=c1nc(OC[C@@H]2COCCO2)cc2n1CCc1c2ccc(c1)C#CC1CC1
InChI InChI=1S/C22H22N2O4/c25-22-23-21(28-14-18-13-26-9-10-27-18)12-20-19-6-5-16(4-3-15-1-2-15)11-17(19)7-8-24(20)22/h5-6,11-12,15,18H,1-2,7-10,13-14H2/t18-/m0/s1
InChI Key IRBAWVGZNJIROV-SFHVURJKSA-N
Download 2D Structure Click here for help
Canonical SMILES Download
Isomeric SMILES Download
InChI standard identifier Download
InChI standard key Download

Molecular structure representations generated using Open Babel